Estimating the prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry testing: data from The National Health and Nutrition Examination Survey, 2007-2010
Public Domain
-
2013/05/01
-
Details
-
Personal Author:
-
Description:Rationale: During 2007-2010, the National Health and Nutrition Examination Survey (NHANES), a nationally representative survey of the non-institutionalized US population, conducted a spirometry component which obtained pre-bronchodilator pulmonary lung function data on survey participants 6-79 years of age and post-bronchodilator pulmonary lung function data for the subset of this group with airflow limitation. Data on respiratory symptoms and other respiratory related data were also collected. These data offered a unique opportunity to examine multiple approaches to estimating the prevalence of COPD in a nationally representative US sample. Methods: NHANES 2007-2010 spirometry data were analyzed. Among those aged 40-79 years, 5,823 received the pre-bronchodilator spirometry. Those with likely airflow limitation were selected for the post-bronchodilator test (n=1,110). Airflow limitation was defined based on two criteria: 1) forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) < 70%1,2; and 2) FEV1/FVC < lower limit of normal (LLN) according to age, sex, height, and race/ethnicity1,3,4. Persons were classified as having chronic obstructive pulmonary disease (COPD) based on 1) having airflow limitation as defined above using pre- or post-bronchodilator values, or 2) reporting the use of daytime supplemental oxygen therapy plus a physician diagnosis of COPD (ever had emphysema or current chronic bronchitis). The final analytic samples for the pre-bronchodilator and post-bronchodilator analyses were 77.1% (n=5,477) and 50.8% (n=564) of those eligible, respectively. To account for this non-response in the estimation of COPD, we used a method where NHANES examination weights were adjusted to the eligible pre-bronchodilator and post-bronchodilator subpopulations. Results: In 2007-2010, using the FEV1/FVC ratio <0.7 diagnostic criterion and pre-bronchodilator test results, the estimated prevalence of COPD was 20.9% (SE 1.1) among US adults aged 40-79 years. Applying the same criterion to post-bronchodilator test results, the prevalence was 14.0% (SE 1.0). Using the FEV1/FVC ratioSubjects:Keywords:ISSN:1073-449XDocument Type:Genre:Place as Subject:CIO:Division:Topic:Location:Volume:187NIOSHTIC Number:nn:20044386Citation:Am J Respir Crit Care Med 2013 May; 187(Meeting Abstracts):A3641Contact Point Address:T. Tilert, CDC/National Center for Health Statistics, Hyattsville, MDFederal Fiscal Year:2013Peer Reviewed:FalseSource Full Name:American Journal of Respiratory and Critical Care MedicineSupplement:Meeting AbstractsCollection(s):Main Document Checksum:urn:sha-512:897bbe23fce6e5aeb3d18beb460df2c3789e966c499a819148e4de65c1f2c6f5293dacde9a774e85b5c4f1c079ad2cc1a86e145c0236817fd2a07868637bbb4fDownload URL:File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like